Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Expert Opinion on Biological Therapy|May 20, 2015
TRUCKs: the fourth generation of CARsMarkus Chmielewski, Hinrich AbkenCell Reports|December 16, 2017
CAR T Cells Releasing IL-18 Convert to T-Bethigh FoxO1low Effectors that Exhibit Augmented Activity against Advanced Solid TumorsMarkus Chmielewski, Hinrich AbkenFrontiers in Immunology|August 29, 2022
Regulatory CAR-T cells in autoimmune diseases: Progress and current challengesTobias Riet, Markus ChmielewskiCancer Immunology, Immunotherapy : CII|January 26, 2012
CAR T cells transform to trucks: chimeric antigen receptor-redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancerMarkus Chmielewski, Hinrich AbkenFrontiers in Immunology|November 26, 2013
Antigen-Specific T-Cell Activation Independently of the MHC: Chimeric Antigen Receptor-Redirected T CellsMarkus Chmielewski, Andreas A Hombach, Hinrich AbkenImmunological Reviews|December 17, 2013
Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stromaMarkus Chmielewski, Andreas A Hombach, Hinrich AbkenOncoimmunology|December 18, 2012
CAR's made it to the pancreasMarkus Chmielewski, Amit Maliar, Zelig Eshhar, et al.Cancer Research|July 12, 2011
IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expressionMarkus Chmielewski, Caroline Kopecky, Andreas A Hombach, et al.Human Gene Therapy|January 29, 2013
Adoptive immunotherapy with redirected T cells produces CCR7- cells that are trapped in the periphery and benefit from combined CD28-OX40 costimulationAndreas A Hombach, Markus Chmielewski, Gunter Rappl, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 9, 2004
T cell activation by antibody-like immunoreceptors: increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivityMarkus Chmielewski, Andreas Hombach, Claudia Heuser, et al.Pageof 4